NAD Nasal Spray in Milwaukee: What the Research Shows

A NAD+ nasal spray is a compounded preparation that delivers nicotinamide adenine dinucleotide through the nasal mucosa instead of by intravenous infusion or injection. Some clinicians offer it as part of a recovery or healthy-aging program. Whether it's appropriate for any given patient is a clinical judgment, not a self-service decision, and the published evidence is still maturing.

In Milwaukee, interest in NAD nasal spray has grown alongside broader curiosity about cellular-energy supplementation, sleep recovery, and post-exertion fatigue — particularly through long Wisconsin winters when training volume drops and recovery feels slower. This article walks through what NAD+ actually is, what peer-reviewed research has and hasn't established, and what to bring up with your provider.

What NAD+ Is and Why People Care About It

Nicotinamide adenine dinucleotide is one of the most abundant coenzymes in human cells. It shuttles electrons through the mitochondria during ATP production, supports DNA repair through the sirtuin and PARP enzyme families, and participates in hundreds of redox reactions across nearly every tissue. Without adequate NAD+, basic cellular metabolism slows down.

What pulled NAD+ into the wellness conversation is a body of mostly preclinical work showing that tissue NAD+ levels decline with age. Reviews in Cell Metabolism (Rajman, Chamberlain, and Sinclair, 2018; Yoshino et al., 2018) describe how NAD+ precursors — nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), and niacin — have been studied as a way to raise NAD+ stores. Most of the human data we have comes from oral precursor studies. Direct administration of the parent NAD+ molecule has a much thinner literature behind it.

How a Nasal Delivery Format Differs From Other Routes

Compounding pharmacies prepare NAD+ in several routes. Intravenous infusions are the most established in clinical settings — they take hours and require trained staff to administer. Subcutaneous formats, like the NAD+ injectable option from Body Good Men, deliver the molecule into adipose tissue for slower absorption. A topical NAD+ cream is sometimes used for localized application. A nasal spray exposes NAD+ to highly vascular nasal mucosa, which is part of why patients ask about it for at-home use.

The trade-off worth understanding: the published pharmacokinetic literature on intranasal NAD+ specifically is thin. Most absorption data describes NAD+ precursors taken orally, not the parent molecule administered through the nose. That's a meaningful caveat your clinician should walk through before recommending a route.

What the Published Research Actually Shows

The strongest human data on raising NAD+ comes from precursor trials. In a randomized, placebo-controlled study, Martens and colleagues (Nature Communications, 2018) gave healthy middle-aged and older adults nicotinamide riboside 500 mg twice daily for six weeks, then crossed over. They measured roughly a 60% increase in whole-blood NAD+ relative to placebo, and the regimen was well tolerated with no serious adverse events attributed to NR. Trammell et al. (Nature Communications, 2016) earlier characterized NR's pharmacokinetics and confirmed dose-dependent elevation of NAD+ metabolites in human blood.

What those studies do not show is an outcome-level guarantee. Biomarkers shifted, but downstream clinical endpoints — physical performance, cognition, post-exertion recovery — were modest, mixed, or not consistently replicated. That's why a careful clinician frames NAD+ supplementation as biologically interesting rather than a proven treatment for fatigue, brain fog, or longevity.

For intranasal NAD+ specifically, rigorous efficacy trials remain limited. Most of the available evidence is observational, mechanistic, or extrapolated from precursor work. Anyone considering the NAD+ nasal spray program at Body Good Men should view the science as evolving and weight that evidence accordingly.

How a Milwaukee Clinician Evaluates a Candidate

Providers in Wisconsin who include NAD+ in their wellness programs typically look at several factors before prescribing:

• Baseline health context. Underlying conditions — hypertension, cardiovascular disease, kidney issues, recent surgery, active malignancy — change the calculus. NAD+ supplementation is not a routine intervention for unscreened patients.
• What problem the patient is actually trying to solve. Generalized fatigue may have endocrine, metabolic, or sleep-related roots that respond better to targeted workup. A thoughtful clinician screens for those first instead of layering on a coenzyme.
• Medication interactions and history. NAD+ has been studied far less extensively than commonly prescribed drugs, and conservative clinicians review the full medication list before starting anything compounded.
• Realistic expectations. A provider who promises a specific outcome from a nasal NAD+ regimen is overpromising. The published literature does not support that confidence.

If you're evaluating providers in the Milwaukee area, ask whether they require an intake review, baseline lab work, and a follow-up cadence — not just a prepay form.

Questions to Bring to Your Provider

• Why might NAD+ be appropriate for my clinical picture, given my labs and symptoms?
• What published research supports the route of administration you're recommending?
• How will we measure whether it's working, and what would prompt us to stop?
• What are the most likely side effects, and how should I report them?
• Are there better-evidenced interventions — sleep hygiene, vitamin D, structured exercise dosing, treating an underlying condition — we should try first?

Common Misconceptions Worth Clearing Up

A few worth dispelling. First, NAD+ is not a stimulant; people sometimes describe a subjective "lift," but the molecule does not act on adrenergic or dopaminergic pathways the way caffeine or amphetamines do. Second, raising NAD+ in blood is not the same as raising NAD+ inside every tissue — the precursor literature shows that distribution between compartments matters. Third, "more is not better." Trials used defined doses, not escalating ones, and the safety record only covers what was actually studied. Finally, NAD+ formats are not interchangeable: nasal, injectable, IV, and topical routes have different pharmacokinetics and different clinical contexts.

Frequently Asked Questions

Is NAD nasal spray FDA-approved?

No. NAD+ administered as a nasal spray is a compounded preparation, not an FDA-approved drug. Compounding pharmacies prepare it under state and federal compounding rules. That is a meaningful distinction from approved medications: the FDA has not reviewed efficacy, dosing, or labeling for any intranasal NAD+ product. Treatment decisions belong to a licensed clinician familiar with compounded preparations and your individual history.

How long does NAD nasal spray take to work?

Published research does not establish a reliable timeline because rigorous human trials of intranasal NAD+ are limited. Precursor studies on NR and NMN showed measurable changes in blood NAD+ over several weeks of consistent use. Subjective reports from patients vary widely and are not a substitute for trial data. Your clinician should set expectations and define what "working" actually looks like before you start.

Can I get NAD nasal spray in Milwaukee through telehealth?

Some telehealth programs serving Wisconsin connect patients with licensed clinicians who, after an evaluation, may prescribe compounded NAD+ preparations through partner pharmacies when appropriate. Eligibility depends on a clinician's review of your medical history, current medications, and goals — not on geography or self-selection. Local in-person providers in the Milwaukee area are also an option if you prefer face-to-face care.

What are the side effects of NAD nasal spray?

The published safety profile for intranasal NAD+ is incomplete. Reported effects from related NAD+ formats include nasal irritation, headache, nausea, flushing, and transient fatigue. Because compounded preparations are not standardized the way FDA-approved drugs are, side-effect reporting depends on the prescribing clinician and the compounding pharmacy. Report any reaction promptly to your provider, and don't continue dosing through unexplained symptoms.

Is NAD nasal spray better than IV NAD+?

The published evidence does not support a clear "better." IV NAD+ has more clinical-setting history, longer infusion exposure, and different pharmacokinetics. Nasal delivery is more convenient and patient-administered. Which route is appropriate — if either — depends on the patient, the clinical question, and the provider's judgment, not on consumer preference alone. Discuss the trade-offs with your clinician before choosing.

Talk to a Clinician About Whether NAD+ Fits

If you're considering NAD+ supplementation and want to know whether it's appropriate for you, talk to a licensed clinician. The clinician-reviewed NAD+ nasal program at Body Good Men connects you with a US-licensed clinician who reviews your eligibility and, if appropriate, prescribes through our partner pharmacy.

Important Disclosure

men.joinbodygood.com is operated as an affiliate of Body Good Studio LLC and is a whitelabel certified partner of Leg Up Rx. men.joinbodygood.com does not provide medical services, prescribe medications, or maintain patient records. All clinical evaluations, prescription decisions, and medication fulfillment are handled by licensed medical and pharmacy partners through Leg Up Rx. This article is for general informational purposes only and is not medical advice. Talk to a licensed healthcare provider before starting any treatment. Eligibility for any medication is determined solely by a licensed clinician.